2010
DOI: 10.1083/jcb.200908103
|View full text |Cite
|
Sign up to set email alerts
|

The Arf tumor suppressor protein inhibits Miz1 to suppress cell adhesion and induce apoptosis

Abstract: Arf assembles a complex containing Miz1, heterochromatin, and histone H3K3 to block expression of genes involved in cell adhesion and signal transduction. The resulting blockade of cell–cell and cell–matrix interactions facilitates elimination of cells carrying oncogenic mutations.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
36
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 40 publications
(38 citation statements)
references
References 47 publications
2
36
0
Order By: Relevance
“…This phenomenon is generally accompanied by a parallel disruption of the inhibitory interaction between Mdm2 and p53, resulting in the accumulation of transcriptionally active p53 that induces specific responses such as cell-cycle arrest or apoptosis [11], [12]. However, genetic analysis of tumors and the evidence that ARF can induce cell-cycle arrest in cells lacking Mdm2 and p53 support the notion that ARF might act independently of MDM2 and p53 [2], [5], [13], [14], [15]. Furthermore, the discovery of a plethora of ARF interactors and the observation that also viral, genotoxic, hypoxic and oxidative stresses activate an ARF-dependent response, suggest that ARF has a wider role to protect the cell [16].…”
Section: Introductionmentioning
confidence: 99%
“…This phenomenon is generally accompanied by a parallel disruption of the inhibitory interaction between Mdm2 and p53, resulting in the accumulation of transcriptionally active p53 that induces specific responses such as cell-cycle arrest or apoptosis [11], [12]. However, genetic analysis of tumors and the evidence that ARF can induce cell-cycle arrest in cells lacking Mdm2 and p53 support the notion that ARF might act independently of MDM2 and p53 [2], [5], [13], [14], [15]. Furthermore, the discovery of a plethora of ARF interactors and the observation that also viral, genotoxic, hypoxic and oxidative stresses activate an ARF-dependent response, suggest that ARF has a wider role to protect the cell [16].…”
Section: Introductionmentioning
confidence: 99%
“…Miz1 is unstable and continuously degraded by the Huwe1 ubiquitin ligase [56]; upon inhibition of Huwe1, Miz1 broadly accumulates at Myc-bound promoters, blunts activation and enhances repression by Myc [56, 57]. Interestingly, the Arf protein binds to and inhibits Huwe1 and promotes association of Myc with Miz1 [58, 59], strongly suggesting that Arf and Miz1 are part of a common stress-response to oncogenic Myc levels.…”
Section: Shaping Transcriptional Amplificationmentioning
confidence: 99%
“…Both proteins exhibit anti-proliferative properties, although mediated through different mechanisms by either activating p53 or interacting with the retinoblastoma protein [10]. ARF associates with a number of proteins promoting their posttranslational modification such as sumoylation and phosphorylation to activate or deactivate their function [11, 12]. Among those pathways, the one most frequently studied and best known, is the involvement of ARF in protecting the transcription factor p53 from degradation by binding to MDM2 [13, 14].…”
Section: Introductionmentioning
confidence: 99%